Search - tctmd.com

Displaying 721 - 740 of 2025

Sort: Relevancy | Date

News Daily News

Unwarranted Stress Testing Before Knee, Hip Surgery Is Declining

Caitlin E. Cox

October 07, 2020

News Daily News

Aspirin Alone After TAVR Supported by Meta-analysis

Todd Neale

September 29, 2020

News Daily News

Making Sense of MI: EXCEL and SYNTAX Tackle Event Definitions

Michael O'Riordan

September 28, 2020

News Daily News

Even in Ideal Patients, Surgeons Aren’t Doing Multiarterial CABG

Shelley Wood

September 28, 2020

News Daily News

Women With Prior SCAD Not Always at Risk of Recurrence in Pregnancy

Caitlin E. Cox

September 25, 2020

In-Stent Restenosis Accounts for 10% of All PCIs, Contemporary National Analysis Shows

News Daily News

In-Stent Restenosis Accounts for 10% of All PCIs, National Analysis Shows

L.A. McKeown

September 24, 2020

News Daily News

Colchicine Shows Potential in Malignant Pericardial Effusion

Caitlin E. Cox

September 21, 2020

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

News Daily News

Renal Function Gains Seen in CKD Patients After TAVR

L.A. McKeown

September 15, 2020

News Daily News

PCI Volumes Rise in US and Japan, but for Different Reasons

Michael O'Riordan

September 14, 2020

News Daily News

TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape

Caitlin E. Cox

September 14, 2020

News Daily News

Which TAVR Device Is Best? Review Tackles Optimal Selection

Michael O'Riordan

September 09, 2020

News Conference News ESC 2020

More Bleeding, Death With Ticagrelor Over Clopidogrel in Elderly Post-MI Patients: SWEDEHEART

Yael L. Maxwell

September 08, 2020

News Conference News ESC 2020

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

Caitlin E. Cox

September 04, 2020

News Conference News ESC 2020

VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban

L.A. McKeown

September 03, 2020

News Conference News ESC 2020

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Caitlin E. Cox

September 03, 2020

News Daily News

Free CAC Scans for ASCVD Risk Capture More Women, Minorities, and Low-Income Adults

Michael O'Riordan

September 02, 2020

News Conference News ESC 2020

HESTIA, Simplified PESI Comparable for Triage to Outpatient PE Treatment: HOME-PE

Todd Neale

September 01, 2020

News Conference News ESC 2020

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Michael O'Riordan

August 31, 2020

News Conference News ESC 2020

EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF

Michael O'Riordan

August 28, 2020

Advertisement

Unwarranted Stress Testing Before Knee, Hip Surgery Is Declining

Aspirin Alone After TAVR Supported by Meta-analysis

Making Sense of MI: EXCEL and SYNTAX Tackle Event Definitions

Even in Ideal Patients, Surgeons Aren’t Doing Multiarterial CABG

Women With Prior SCAD Not Always at Risk of Recurrence in Pregnancy

In-Stent Restenosis Accounts for 10% of All PCIs, National Analysis Shows

Colchicine Shows Potential in Malignant Pericardial Effusion

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Renal Function Gains Seen in CKD Patients After TAVR

PCI Volumes Rise in US and Japan, but for Different Reasons

TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape

Which TAVR Device Is Best? Review Tackles Optimal Selection

More Bleeding, Death With Ticagrelor Over Clopidogrel in Elderly Post-MI Patients: SWEDEHEART

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Free CAC Scans for ASCVD Risk Capture More Women, Minorities, and Low-Income Adults

HESTIA, Simplified PESI Comparable for Triage to Outpatient PE Treatment: HOME-PE

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content